Return to Trial Database

HCRN-NHL00-1

A Phase II Study of Single Agent Gemcitabine In Relapsed or Refractory Follicular or Small Lymphocytic Non-Hodgkin’s Lymphoma

Status

Study Completed

Cancer Type(s)

Study Contact

Publications

A Phase II Study of Single Agent Gemcitabine in Relapsed or Refractory Follicular or Small Lymphocytic non-Hodgkin’s Lymphomas

Trial Locations

All sites in which the trial HCRN-NHL00-1 being conducted in.

No data was found